Introduction

Breast Pathology - Masters of Pathology Series focuses on best practices and current concepts in breast pathology and is designed to vastly improve physician skill sets in the practice of 21st century breast pathology. The program focuses on lab quality issues, accurate diagnosis of lesions, stromal and fibroepithelial breast tumors and proper biomarker interpretation of breast carcinomas. Led by a renowned breast pathologist, David J. Dabbs, MD, it will significantly enhance your diagnostic skills and help to improve patient outcomes via a concise presentation of 15 state-of-the-art lectures.

The course will help you to better:

• Discuss the proper fixation and tissue processing for breast core biopsies, excisional biopsies and mastectomy specimens.
• Recognize the most common inflammatory and reactive lesions of the breast and distinguish them from malignant tumors.
• Distinguish lobular from ductal lesions, distinguish fibroepithelial tumors, recognize rare types of breast carcinoma, and identify breast tumors that occur in children.
• Understand the principles of antibodies used in breast pathology to make accurate diagnoses.
• Understand the critical importance of hormone receptor and Her2 analysis.
• Discuss the molecular classification of breast cancers and understand the role of neoadjuvant chemotherapy for breast tumors.

Who Should Enroll

Pathologists in practice and pathology residents in training, those interested in breast pathology.

Course Design

Watch anytime, anywhere, on virtually any reliable Internet-connected device (some connections may not provide optimal results), simply log in and watch as much as you want — no downloading necessary.

Course Content

Learning Outcomes

At the conclusion of this CME activity, the participant will be able to:

• Discuss the proper fixation and tissue processing for breast core biopsies, excisional biopsies and mastectomy specimens.
• Recognize the most common inflammatory and reactive lesions of the breast and be able to distinguish them from malignant tumors.
• State the most common fibroepithelial tumors of the breast and be able to distinguish them from each other based on established diagnostic criteria and outcomes.
• Be able to recognize columnar cell alterations and distinguish them from atypical duct hyperplasia, usual duct hyperplasia, duct carcinoma in situ and flat epithelial atypia.
• Be able to distinguish lobular from ductal lesions and discuss their molecular classification and surrogates and understand why this is important for laboratory metrics.
• Understand the principles of antibodies used in breast pathology to make accurate diagnoses, and understand their pitfalls of interpretation.
• Understand the critical importance of hormone receptor and Her2 analysis using immunohistochemistry and how proper use of these tests drive patient therapies.
• Be able to discuss the molecular classification of breast cancers and understand the immunohistochemical surrogates of this classification.
• Be able to list and accurately recognize special and rare types of breast carcinoma, and accurately distinguish them from metastasis to the breast.
• Understand the role of neoadjuvant chemotherapy (NACT) for breast tumors, and be able to accurately assess breast specimens from patients who have had NACT.
• Outline the tumors that occur in children and adolescents and be able to discuss how they differ from their adult counterparts.
• List the common mesenchymal and hematopoetic tumors that occur in the breast and be able to accurately diagnose them.

Faculty

Course Director

David J. Dabbs, MD
Professor and Chief of Pathology
Magee-Women’s Hospital of UPMC
Pittsburgh, PA
Chief of Breast Pathology
UPMC Health System

Accreditation

Accredited according to HCPSA's Medical and Dental Board Guidelines for Healthcare Professionals for 16 Clinical CEUs on Level 2.

Kindly note that the accreditation will be completed by The Foundation for Professional Development (FPD) – a private-higher education institution and an accredited service provider under registration of the South African Medical Association (SAMA).

Certification

To qualify for the certificate of completion for this CPD/CME course, participants should successfully complete the course assessment process.

Assessment

Participants will be assessed by means of a multiple-choice questionnaire and have 3 months for completion from date of registration.

Contact

For more information contact:

School of Health Sciences